[HTML][HTML] FXR acts as a metastasis suppressor in intrahepatic cholangiocarcinoma by inhibiting IL-6-induced epithelial-mesenchymal transition

B Lv, L Ma, W Tang, P Huang, B Yang… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: Intrahepatic cholangiocarcinoma (ICC) is a complicated condition, with
difficult diagnosis and poor prognosis. The expression and clinical significance of the …

FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.

B Lv, L Ma, W Tang, P Huang, B Yang… - Cellular Physiology …, 2018 - search.ebscohost.com
Abstract < bold> Background/Aims: </bold> Intrahepatic cholangiocarcinoma (ICC)
is a complicated condition, with difficult diagnosis and poor prognosis. The expression and …

FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition

B Lv, L Ma, W Tang, P Huang, B Yang… - Cellular Physiology …, 2018 - search.proquest.com
Background/Aims: Intrahepatic cholangiocarcinoma (ICC) is a complicated condition, with
difficult diagnosis and poor prognosis. The expression and clinical significance of the …

FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.

B Lv, L Ma, W Tang, P Huang, B Yang… - Cellular Physiology …, 2018 - go.gale.com
Background/Aims: Intrahepatic cholangiocarcinoma (ICC) is a complicated condition, with
difficult diagnosis and poor prognosis. The expression and clinical significance of the …

[PDF][PDF] FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition

BLL Maa, W Tanga, P Huanga, B Yanga… - Cell Physiol …, 2018 - scholar.archive.org
Abstract Background/Aims: Intrahepatic cholangiocarcinoma (ICC) is a complicated
condition, with difficult diagnosis and poor prognosis. The expression and clinical …

FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition

B Lv, L Ma, W Tang, P Huang, B Yang, L Wang, S Chen… - 2018 - agris.fao.org
Background/Aims: Intrahepatic cholangiocarcinoma (ICC) is a complicated condition, with
difficult diagnosis and poor prognosis. The expression and clinical significance of the …

FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.

B Lv, L Ma, W Tang, P Huang, B Yang… - Cellular Physiology …, 2018 - europepmc.org
Methods Western blotting and immunochemical analyses were used to determine the levels
of FXR in 4 cholangiocarcinoma cell lines, a human intrahepatic biliary epithelial cell line …

FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition

B Lv, L Ma, W Tang, P Huang, B Yang… - Cellular Physiology and …, 2018 - karger.com
Abstract Background/Aims: Intrahepatic cholangiocarcinoma (ICC) is a complicated
condition, with difficult diagnosis and poor prognosis. The expression and clinical …

FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition

B Lv, L Ma, W Tang, P Huang, B Yang, L Wang… - Cellular Physiology and …, 2018 - cir.nii.ac.jp
抄録< jats: p> Background/Aims: Intrahepatic cholangiocarcinoma (ICC) is a complicated
condition, with difficult diagnosis and poor prognosis. The expression and clinical …

FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition

B Lv, L Ma, W Tang, P Huang… - Cellular physiology …, 2018 - pubmed.ncbi.nlm.nih.gov
Background/aims Intrahepatic cholangiocarcinoma (ICC) is a complicated condition, with
difficult diagnosis and poor prognosis. The expression and clinical significance of the …